Premium
Future Clinical Pharmacy Practitioners Should Be Board‐Certified Specialists
Author(s) -
Saseen Joseph J.,
Grady Sarah E.,
Hansen Laura B.,
Hodges Brian M.,
Kovacs Steven J.,
Martinez Larry D.,
Murphy John E.,
Page Robert L.,
Reichert Marc G.,
Stringer Kathleen A.,
Taylor Charles T.
Publication year - 2006
Publication title -
pharmacotherapy: the journal of human pharmacology and drug therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.227
H-Index - 109
eISSN - 1875-9114
pISSN - 0277-0008
DOI - 10.1592/phco.26.12.1816
Subject(s) - reprint , pharmacy , suite , download , library science , medicine , family medicine , political science , world wide web , computer science , law , physics , astronomy
The vision of the American College of Clinical Pharmacy (ACCP) is that, in 20–30 years, most clinical pharmacy practitioners will be boardcertified specialists. 2 This White Paper develops a rationale for this position, describes specialty board certification in pharmacy, and articulates recommendations for attaining the vision. The justification of the need for board certification as a part of future quality assurance and professional privileging processes, the rationale for the argument that most future clinical faculty and residency preceptors should be board certified, and the identification of obstacles that hinder achieving this vision are also discussed.